APA

Becker M., Graf C., Tonak M., Radsak M. P., Bopp T., Bals R., Bohle R. M., Theobald M., Rommens P., Proschek D. & Wehler T. C. (2016). Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. : Oncology letters.

Chicago

Becker Marc, Graf Claudine, Tonak Marcus, Radsak Markus P, Bopp Tobias, Bals Robert, Bohle Rainer M, Theobald Matthias, Rommens Pol-Maria, Proschek Dirk and Wehler Thomas C. 2016. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. : Oncology letters.

Harvard

Becker M., Graf C., Tonak M., Radsak M. P., Bopp T., Bals R., Bohle R. M., Theobald M., Rommens P., Proschek D. and Wehler T. C. (2016). Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. : Oncology letters.

MLA

Becker Marc, Graf Claudine, Tonak Marcus, Radsak Markus P, Bopp Tobias, Bals Robert, Bohle Rainer M, Theobald Matthias, Rommens Pol-Maria, Proschek Dirk and Wehler Thomas C. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. : Oncology letters. 2016.